よむ、つかう、まなぶ。
15参考資料２－５ 百日せきワクチン ファクトシート 平成 29(2017）年 2 月 10 日 (44 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/shingi2/0000192554_00024.html |
| 出典情報 | 厚生科学審議会予防接種・ワクチン分科会 予防接種基本方針部会（第49回 10／4）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
dose to prevent pertussis in the United States. Vaccine.2016. 34:1832-8.
102. Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, Rebmann
CA, Gabel J, Schauer SL, Lett SM. Infant pertussis; who was the source ? Pediatric
Infectious Disease J. 2000.23:985-9.
103. Center for Disease Control and Prevention. Updated Recommendations for Use of Tetanus
Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine in Pregnant
Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged
Less than 12 Months — Advisory Committee on Immunization Practices (ACIP), 2011.
MMWR. 2011. 60:1424–6.
104. Center for Disease Control and Prevention. Updated Recommendations for Use of Tetanus
Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine in Pregnant
Women -- Advisory Committee on Immunization Practices (ACIP), 2012. MMWR.
2013.62:131–5.
105. Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, Fry NK, Miller
E, Ramsay M. Effectiveness of maternal pertussis vaccination in England: an observational
study. Lancet. 2014. 384:1521-8.
106. Walls T, Graham P, Petousis-Harris H, Hill L, Austin N. Infant outcomes after exposure to
Tdap vaccine in pregnancy: an observational study. BMJ Open. 2016. 6: e009536.
doi:10.1136/bmjopen-2015-009536
107. カリフォルニア州公衆衛生局(CDPH). Pertussis report 2015-1-7. 2015.
108. Winter K, Glaser C, Watt J, Harriman K; Centers for Disease Control and Prevention
(CDC). Pertussis epidemic--California, 2014. MMWR Morb Mortal Wkly Rep. 2014. 63:
1129-32.
109. オーストラリア保健省. Notifications of a selected disease by month and year, 1991 to
present: Pertussis. http://www9.health.gov.au/cda/source/rpt_3_sel.cfm.
110. Pillsbury A, Quinn HE and McIntyre PB. Australian vaccine preventable disease
epidemiological review series: pertussis, 2006-2012. Commun Dis Intell Q Rep 2014. 38:
E179-94.
111. オーストラリア保健省. Australia’s notifiable disease status, 2012: Annual report of the
National Notifiable Diseases Surveillance System - Part 3. http://www.mbsonline.gov.au
112. Amirthalingam G. Strategies to control pertussis in infants. Arch Dis Child. 2013. 98:
552-5.
113. Amirthalingam G, Gupta S and Campbell H. Pertussis immunisation and control in
England and Wales, 1957 to 2012: a historical review. Euro Surveill 2013. 18. pii: 20587.
114. 一般財団法人阪大微生物病研究会.「沈降精製百日せきジフテリア破傷風混合ワク
チン」トリビック®に関する資料
43
102. Bisgard KM, Pascual FB, Ehresmann KR, Miller CA, Cianfrini C, Jennings CE, Rebmann
CA, Gabel J, Schauer SL, Lett SM. Infant pertussis; who was the source ? Pediatric
Infectious Disease J. 2000.23:985-9.
103. Center for Disease Control and Prevention. Updated Recommendations for Use of Tetanus
Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine in Pregnant
Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged
Less than 12 Months — Advisory Committee on Immunization Practices (ACIP), 2011.
MMWR. 2011. 60:1424–6.
104. Center for Disease Control and Prevention. Updated Recommendations for Use of Tetanus
Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine in Pregnant
Women -- Advisory Committee on Immunization Practices (ACIP), 2012. MMWR.
2013.62:131–5.
105. Amirthalingam G, Andrews N, Campbell H, Ribeiro S, Kara E, Donegan K, Fry NK, Miller
E, Ramsay M. Effectiveness of maternal pertussis vaccination in England: an observational
study. Lancet. 2014. 384:1521-8.
106. Walls T, Graham P, Petousis-Harris H, Hill L, Austin N. Infant outcomes after exposure to
Tdap vaccine in pregnancy: an observational study. BMJ Open. 2016. 6: e009536.
doi:10.1136/bmjopen-2015-009536
107. カリフォルニア州公衆衛生局(CDPH). Pertussis report 2015-1-7. 2015.
108. Winter K, Glaser C, Watt J, Harriman K; Centers for Disease Control and Prevention
(CDC). Pertussis epidemic--California, 2014. MMWR Morb Mortal Wkly Rep. 2014. 63:
1129-32.
109. オーストラリア保健省. Notifications of a selected disease by month and year, 1991 to
present: Pertussis. http://www9.health.gov.au/cda/source/rpt_3_sel.cfm.
110. Pillsbury A, Quinn HE and McIntyre PB. Australian vaccine preventable disease
epidemiological review series: pertussis, 2006-2012. Commun Dis Intell Q Rep 2014. 38:
E179-94.
111. オーストラリア保健省. Australia’s notifiable disease status, 2012: Annual report of the
National Notifiable Diseases Surveillance System - Part 3. http://www.mbsonline.gov.au
112. Amirthalingam G. Strategies to control pertussis in infants. Arch Dis Child. 2013. 98:
552-5.
113. Amirthalingam G, Gupta S and Campbell H. Pertussis immunisation and control in
England and Wales, 1957 to 2012: a historical review. Euro Surveill 2013. 18. pii: 20587.
114. 一般財団法人阪大微生物病研究会.「沈降精製百日せきジフテリア破傷風混合ワク
チン」トリビック®に関する資料
43